IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations

Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells

(2012) Keiko Kajitani et al.   BREAST CANCER RESEARCH AND TREATMENT

Interleukin-21 in cancer immunotherapy

(2012) Carmine Stolfi et al.   OncoImmunology

Association between interleukin 21 and Graves’ disease

(2011) H.Y. Jia et al.   GENETICS AND MOLECULAR RESEARCH

The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1

(2010) Susan D. Thompson et al.   ARTHRITIS AND RHEUMATISM

Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis

(2010) Jian Zheng et al.   BMC CANCER

A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population

(2010) Lan Jiang et al.   BREAST CANCER RESEARCH AND TREATMENT

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation

(2009) Julián Pardo et al.   MICROBES AND INFECTION

IL-21: roles in immunopathology and cancer therapy

(2009) H. Søndergaard et al.   TISSUE ANTIGENS

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

(2007) Rosanne Spolski et al.   Annual Review of Immunology